← Back to Search

Corticosteroid

Hyaluronic + Corticosteroid Injections and Physical Therapy for Hip Issues (NON-OP HIP Trial)

N/A

Waitlist Available

Research Sponsored by ArthroBiologix Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients aged 40-60 years old

Patients who demonstrate more than 50% reduction in hip pain following a diagnostic injection (ultrasound guided intra-articular anaesthetic only)

Must not have

Previous surgery to the pelvis, hip or lower limb

Active infection

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months post-injection

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study the effectiveness of combining physiotherapy with corticosteroid and hyaluronic acid injections for treating hip pathologies. Hip issues like FAI, labral tears,

Who is the study for?

This trial is for individuals with mild-to-moderate hip pain and functional limitations due to conditions like femoroacetabular impingement, labral tears, or osteoarthritis. It's not suitable for those needing surgery or who have severe symptoms.

What is being tested?

The study tests if combining a corticosteroid and hyaluronic acid injection with physiotherapy improves outcomes in hip pathology patients compared to the injection alone.

What are the potential side effects?

Potential side effects may include temporary pain at the injection site, infection risk, allergic reactions, and possible worsening of joint inflammation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 40 and 60 years old.

Select...

My hip pain reduced by more than half after a diagnostic injection.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had surgery on my pelvis, hip, or lower limb.

Select...

I currently have an infection.

Select...

I have severe hip problems, including osteonecrosis or advanced arthritis.

Select...

I have had a hip, pelvic, or lower limb fracture before.

Select...

I have a condition like Ehler's-Danlos or Marfan's syndrome.

Select...

I have had a hyaluronic acid injection before.

Select...

I cannot receive corticosteroid or hyaluronic acid injections due to health reasons.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months post-injection

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months post-injection

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-injection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Numeric Pain Rating Scale (NPRS)

Secondary study objectives

Adverse Events

EuroQol-5D-5L (EQ-5D)

International Hip Outcome Tool 12 item (iHOT-12)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Hyaluronic and corticosteroid injection with physical therapyExperimental Treatment2 Interventions

Patients will receive an ultrasound-guided injection consisting of 3 ml hyaluronic acid (Durolane™) mixed with 40 mg triamcinolone (Kenalog™) into their hip joint. Patients will also receive an 8-week physiotherapy protocol, consisting of 8 visits. The protocol will consist of 1 visit per week.

Group II: Hyaluronic and corticosteroid injectionActive Control1 Intervention

Patients will receive an ultrasound-guided injection consisting of 3 ml hyaluronic acid (Durolane™) mixed with 40 mg triamcinolone (Kenalog™) into their hip joint.

0 / 9Eligibility criteria met